细胞内和外体ncRNAs对癌症进展的影响
1Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. yhlin0621@cgmh.org.tw.
Cancer gene therapy
|October 26, 2023
概括
外体内非编码RNAs (ncRNAs) 是癌症进展的关键调节者. 这项研究回顾了它们的作用,外体转移机制和癌症发展中的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 改变基因表达和蛋白质错位导致疾病和癌症.
- 外体细胞作为细胞间通讯器,显著影响癌症的进展.
- 非编码RNAs (ncRNAs) 是细胞过程的关键调节者,包括生长,运动和耐药性.
研究的目的:
- 综合审查细胞内和外体ncRNAs在癌症进展中的功能性作用.
- 讨论ncRNAs被纳入外体的机制.
- 探索外体在癌症治疗中的治疗应用和局限性.
主要方法:
- 文献综述和现有关于ncRNAs和癌症外体的研究的综合.
- 对研究的分析,重点是ncRNA调节,外体转移机制和治疗策略.
- 外体被用作讨论的模型系统.
主要成果:
- 与细胞内ncRNA相比,外体ncRNA在调解下游效应方面发挥着不同的作用.
- 了解ncRNA在外体体中的结合对于利用它们的治疗潜力至关重要.
- 外体为癌症治疗提供了有前途的途径,但需要解决局限性问题.
结论:
- ncRNAs,特别是它们的外体形式,是癌症发展的关键调节者.
- 对ncRNA-外体相互作用的进一步研究对于开发新型癌症疗法至关重要.
- 基于外体的治疗方法具有显著的前景,但需要仔细考虑当前的局限性.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


